Nathalia Almeida

ORCID: 0000-0003-3145-186X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Toxoplasma gondii Research Studies
  • Long-Term Effects of COVID-19
  • Herpesvirus Infections and Treatments
  • Cytomegalovirus and herpesvirus research
  • Multisensory perception and integration
  • SARS-CoV-2 detection and testing
  • Visual perception and processing mechanisms
  • Mosquito-borne diseases and control
  • Neuroscience and Music Perception
  • Pluripotent Stem Cells Research
  • Single-cell and spatial transcriptomics
  • Innovation and Socioeconomic Development
  • CRISPR and Genetic Engineering

King's College London
2020-2024

Guy's Hospital
2020-2021

Universidade de São Paulo
2016-2020

University of Sheffield
2017

COVID-19 vaccine design and vaccination rollout need to take into account a detailed understanding of antibody durability cross-neutralizing potential against SARS-CoV-2 emerging variants concern (VOCs). Analyses convalescent sera provide unique insights longevity activity induced by variant spike proteins, which are putative candidates. Using from 38 individuals infected in wave 1, we show that can be detected up 305 days pos onset symptoms, although were less potent B.1.1.7 (Alpha) B1.351...

10.1038/s41564-021-00974-0 article EN cc-by Nature Microbiology 2021-10-15

Toxoplasmosis is caused by the parasite Toxoplasma gondii that can infect central nervous system (CNS), promoting neuroinflammation, neuronal loss, neurotransmitter imbalance and behavioral alterations. T. infection also related to neuropsychiatric disorders such as schizophrenia. The pathogenicity inflammatory response in rodents are different case of humans, compromising correlation between alterations physiological modifications observed disease. In present work we used BrainSpheres, a 3D...

10.1016/j.bbih.2020.100190 article EN cc-by-nc-nd Brain Behavior & Immunity - Health 2020-12-08

As SARS-CoV-2 variants continue to emerge globally, a major challenge for COVID-19 vaccination is the generation of durable antibody response with cross-neutralizing activity against both current and newly emerging viral variants. Cross-neutralizing concern (B.1.1.7, P.1 B.1.351) has been observed following vaccination, albeit at reduced potency, but whether vaccines based on Spike glycoprotein these will produce superior not fully investigated. Here, we used sera from individuals infected...

10.1101/2021.06.07.21258351 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-06-08

The role of myeloid cells in the pathogenesis SARS-CoV-2 is well established, particular as drivers cytokine production and systemic inflammation characteristic severe COVID-19. However, potential for to act bona fide targets productive infection, specifics entry, remain unclear. Using a panel anti-SARS-CoV-2 monoclonal antibodies (mAbs) we performed detailed assessment antibody-mediated infection monocytes/macrophages. mAbs with most consistent mediate were those targeting conserved region...

10.1038/s41467-024-54458-w article EN cc-by Nature Communications 2024-12-30

ABSTRACT Background Toxoplasmosis is caused by the parasite Toxoplasma gondii that can infect central nervous system (CNS), promoting neuroinflammation, neuronal loss, neurotransmitter imbalance and behavioral alterations. T . infection also related to neuropsychiatric disorders such as schizophrenia. The pathogenicity inflammatory response in rodents are different case of humans, compromising correlation between alterations physiological modifications observed disease. In present work we...

10.1101/2020.08.31.274985 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-08-31
Coming Soon ...